1. Home
  2. IVVD vs CBAT Comparison

IVVD vs CBAT Comparison

Compare IVVD & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • CBAT
  • Stock Information
  • Founded
  • IVVD 2020
  • CBAT 1999
  • Country
  • IVVD United States
  • CBAT China
  • Employees
  • IVVD N/A
  • CBAT N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • CBAT Industrial Machinery/Components
  • Sector
  • IVVD Health Care
  • CBAT Miscellaneous
  • Exchange
  • IVVD Nasdaq
  • CBAT Nasdaq
  • Market Cap
  • IVVD 96.7M
  • CBAT 90.4M
  • IPO Year
  • IVVD 2021
  • CBAT N/A
  • Fundamental
  • Price
  • IVVD $0.73
  • CBAT $0.90
  • Analyst Decision
  • IVVD Strong Buy
  • CBAT
  • Analyst Count
  • IVVD 3
  • CBAT 0
  • Target Price
  • IVVD $5.85
  • CBAT N/A
  • AVG Volume (30 Days)
  • IVVD 653.6K
  • CBAT 189.6K
  • Earning Date
  • IVVD 08-13-2025
  • CBAT 08-12-2025
  • Dividend Yield
  • IVVD N/A
  • CBAT N/A
  • EPS Growth
  • IVVD N/A
  • CBAT N/A
  • EPS
  • IVVD N/A
  • CBAT 0.00
  • Revenue
  • IVVD $36,688,000.00
  • CBAT $152,731,078.00
  • Revenue This Year
  • IVVD $345.16
  • CBAT N/A
  • Revenue Next Year
  • IVVD $161.08
  • CBAT $78.62
  • P/E Ratio
  • IVVD N/A
  • CBAT $214.93
  • Revenue Growth
  • IVVD N/A
  • CBAT N/A
  • 52 Week Low
  • IVVD $0.35
  • CBAT $0.57
  • 52 Week High
  • IVVD $2.74
  • CBAT $1.31
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 46.86
  • CBAT 30.17
  • Support Level
  • IVVD $0.68
  • CBAT $0.80
  • Resistance Level
  • IVVD $0.86
  • CBAT $1.15
  • Average True Range (ATR)
  • IVVD 0.05
  • CBAT 0.07
  • MACD
  • IVVD -0.00
  • CBAT -0.02
  • Stochastic Oscillator
  • IVVD 36.09
  • CBAT 27.14

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

Share on Social Networks: